文献速递新发突发、热带与寄生虫病

改良多重RT-qPCR可揭示传播阻断药物对恶性疟原虫配子体的性别特异性活性

An improved multiplex RT-quantitative PCR assay can reveal sex-specific activity of transmission-blocking drugs on ex vivo gametocytes from Plasmodium falciparum asymptomatic infections.
PubMed 文献 · J Antimicrob Chemother · 2025-01-01

本研究开发了一种多重RT-qPCR方法,通过检测pfCCp4和pfMGET性别特异性转录本,评估药物对恶性疟原虫配子体活性的影响。在离体配子体实验中,亚甲蓝(5 µM)使pfMGET和pfCCp4转录本分别降低30%和80%,P218(0.25 µM)使两者均降低75%。该检测可区分药物对雌雄配子体的不同效应,为传播阻断药物开发提供工具。

要点

  • 多重RT-qPCR可定量恶性疟原虫雌雄配子体转录本pfCCp4和pfMGET。
  • 亚甲蓝(5 µM)降低pfMGET 30%、pfCCp4 80%,P218(0.25 µM)两者均降75%。
  • 部分药物需停药后额外48小时孵育才能检测到转录本下降。

核心结论

  • 多重RT-qPCR检测可可靠评估药物对恶性疟原虫配子体的抑制效果,并能区分对雌雄配子体的性别特异性影响。

研究设计与样本

  • 研究优化了整合内参转录本的多重RT-qPCR检测,采用ΔΔCt法定量配子体转录本水平。
  • 检测应用于恶性疟原虫自然感染的离体配子体,暴露于六种损害蚊媒传播的药物24小时,并以直接膜喂养实验测定传播阻断效果。
  • 后续体外实验显示,药物洗脱后需额外48小时孵育才能监测转录本水平下降及潜在性别特异性效应。

主要发现

  • 亚甲蓝(5 µM)处理样本中,pfMGET转录本降低30%,pfCCp4转录本降低80%。
  • P218(0.25 µM)处理样本中,两种性别特异性转录本均降低75%。
  • 其余药物需在药物洗脱后48小时孵育才能检测到转录本水平下降。
  • 两种药物显示雄性与雌性配子体转录本水平存在差异性降低,提示性别特异性效应。

临床怎么用

  • 该检测可用于评估传播阻断药物对恶性疟原虫配子体总体及性别特异性的活性,支持药物开发与评价。

局限性

  • 原文未述局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: To develop a multiplex RT-quantitative PCR (RT-qPCR) assay to quantify sex-specific Plasmodium falciparum gametocyte transcripts (pfCCp4, pfMGET), for evaluating the impact of drug treatments on gametocyte viability for malaria transmission-blocking drug development. METHODS: We optimized an RT-qPCR assay incorporating a normalization transcript to use the ΔΔCt method (differences in Cycle threshold) to quantify gametocyte transcript levels. The assay was used on ex vivo gametocytes from P. falciparum natural infections exposed for 24 h to six drugs impairing mosquito transmission, as measured by the direct membrane feeding assay. Follow-up in vitro experiments showed that an additional 48 h incubation, following drug wash-out, was required to monitor decline in transcript levels and potential sex-specific effects. RESULTS: The optimized assay revealed efficacy of drug treatment as a reduction in transcript levels for two of the six drugs tested: 30% for pfMGET and 80% for pfCCp4 in methylene blue (5 µM)-treated samples, and 75% for both sex-specific transcripts in samples treated with P218 (0.25 µM). In the remaining drugs, a 48 h incubation period post drug wash-out was required to measure a decline in transcript levels. Furthermore, a differential reduction in the levels of male versus female gametocyte transcripts suggested sex-specific effects for two of the drugs. CONCLUSIONS: The multiplex RT-qPCR assay provides a reliable method to assess the inhibitory effects of drug treatments on P. falciparum gametocytes, with the potential to evaluate both overall and sex-specific impacts on gametocyte viability. This assay represents a valuable tool in the development and evaluation of transmission-blocking drugs, particularly in distinguishing effects on male and female gametocytes.

来源:J Antimicrob Chemother,查看原文。版权归原作者所有。

引用

  1. Ciardo M, Henry NB, Soulama I, et al. An improved multiplex RT-quantitative PCR assay can reveal sex-specific activity of transmission-blocking drugs on ex vivo gametocytes from Plasmodium falciparum asymptomatic infections. J Antimicrob Chemother. 2025. PMID: 40405864. doi:10.1093/jac/dkaf146

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。